FinalDose Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 12

FinalDose General Information

Description

Developer of a programmable cell elimination platform intended to target and destroy diseased cells. The company's platform offers deoxyribonucleic acid-sensing protein engineering, structural change hijacking, and molecular kill switch triggering, enabling healthcare professionals to treat previously undruggable genetic mutations and cancers.

Contact Information

Website
www.finaldose.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • London
  • England, United Kingdom
Primary Industry
Drug Discovery
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • London
  • England, United Kingdom

FinalDose Timeline

2026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FinalDose Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 06-Jun-2026 Completed Startup
1. Accelerator/Incubator 01-Jan-2026 Completed Startup
To view FinalDose’s complete valuation and funding history, request access »

FinalDose Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FinalDose Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Batch Ventures (California) Venture Capital Minority
First Peak Ventures Venture Capital Minority
Founder Factor Venture Capital Minority
Lobster Capital Venture Capital Minority
Multimodal Ventures Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

FinalDose FAQs

  • When was FinalDose founded?

    FinalDose was founded in 2025.

  • Where is FinalDose headquartered?

    FinalDose is headquartered in London, United Kingdom.

  • What is the size of FinalDose?

    FinalDose has 5 total employees.

  • What industry is FinalDose in?

    FinalDose’s primary industry is Drug Discovery.

  • Is FinalDose a private or public company?

    FinalDose is a Private company.

  • What is FinalDose’s current revenue?

    The current revenue for FinalDose is .

  • How much funding has FinalDose raised over time?

    FinalDose has raised $500K.

  • Who are FinalDose’s investors?

    Batch Ventures (California), First Peak Ventures, Founder Factor, Lobster Capital, and Multimodal Ventures are 5 of 12 investors who have invested in FinalDose.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process